Crossmark

Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine

Published Online: 2021-05-13

Published Print: 2021-12

Authors

Voruz, Sophie http://orcid.org/0000-0002-3750-0178
de Leval, Laurence

Cairoli, Anne
License Information

Text and Data Mining valid from 2021-05-13

Version of Record valid from 2021-05-13
More Information

Article History

Received: 8 March 2021

Accepted: 3 May 2021

First Online: 13 May 2021

Declarations

:

: Not applicable.

: The patient gave his written consent to this publication.

: The authors report no conflicts of interest in this work.

Document is current